5-122775115-G-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_003100.4(SNX2):āc.12G>Cā(p.Glu4Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000267 in 1,590,122 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_003100.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000296 AC: 45AN: 152204Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000466 AC: 98AN: 210244Hom.: 1 AF XY: 0.000479 AC XY: 54AN XY: 112626
GnomAD4 exome AF: 0.000264 AC: 379AN: 1437800Hom.: 3 Cov.: 29 AF XY: 0.000312 AC XY: 222AN XY: 712444
GnomAD4 genome AF: 0.000295 AC: 45AN: 152322Hom.: 0 Cov.: 32 AF XY: 0.000322 AC XY: 24AN XY: 74478
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 23, 2021 | The c.12G>C (p.E4D) alteration is located in exon 1 (coding exon 1) of the SNX2 gene. This alteration results from a G to C substitution at nucleotide position 12, causing the glutamic acid (E) at amino acid position 4 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at